Facilities

Ulysses Neuroscience Ltd.’s strategic move to the newly built Pioneer Group life sciences facilities in Cherrywood (Dublin) has not only initiated a transformative phase of growth but has also opened doors to a new industry network that will prove to be fundamental for our future endeavors. This relocation, driven by our vision to be the vanguard CRO in neuroscience drug discovery, showcases the commitment of our dedicated staff and highlights the exceptional quality of our newly acquired facilities and laboratories.  Our new laboratories in Cherrywood are dedicated to perform and progress the company ex-vivo biomarker and in-vitro cell cultures operations. Ulysses Neuroscience Ltd. new laboratories in Cherrywood are fully equipped for analysis of central and peripheral biomarkers related to neuroinflammation, synaptic plasticity and cytoskeleton integrity. The Ulysses team has now collected significant data and performed several studies that clearly underline the importance of these biomarkers in psychiatric and rare CNS diseases in bridging preclinical and clinical research. The cutting-edge cell culture facilities in Cherrywood represent a novel added force to Ulysses Neuroscience ltd. driving the implementation of our in-vitro cell culture platform.